HER2 Aberrations in NSCLC: So Close Yet So Far

Giulia Sartori¹, Lorenzo Belluomini¹, Rosalinda Trovato¹+5

• ¹Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.